STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Clinical trials for STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested to fight tough head and neck cancers
Disease control OngoingThis study is testing whether combining two existing drugs, pembrolizumab and cabozantinib, can help control advanced head and neck cancer that has come back or spread. It will involve about 36 patients whose cancer cannot be removed by surgery. The main goal is to see how many p…
Matched conditions: STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists test new weapon to boost cancer treatment
Disease control OngoingThis early-stage study is testing whether adding an experimental drug called berzosertib to standard chemotherapy (cisplatin) and radiation can better treat advanced head and neck cancer. The main goals are to find the safest and most effective dose of this new combination and to…
Matched conditions: STAGE IV LARYNGEAL SQUAMOUS CELL CARCINOMA AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC